Idiopathic Pulmonary Fibrosis

Latest News in Idiopathic Pulmonary Fibrosis

June 26, 2024

Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study – Frontiers

June 26, 2024

Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study – Frontiers

June 26, 2024

Integrated ML-Based Strategy Identifies Drug Repurposing for Idiopathic Pulmonary Fibrosis – ACS Publications

June 26, 2024

Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine – Frontiers

June 26, 2024

Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics – Frontiers

122 Active Idiopathic Pulmonary Fibrosis Clinical Trials

As of November 12, 2024

Source: clinicaltrials.gov

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

FIND

A DOCTOR EXPERT™

WHAT IS

CONGRESS DOING?